✦ LIBER ✦

P592 A phase 1, double-blind placebo-controlled single-dose study to determine the immune response to systemic and mucosal antigenic challenge in the presence of vedolizumab

✍ Scribed by Wyant, T.; Leach, T.; Sankoh, S.; Wang, Y.; Paolino, J.; Feagan, B.; Parikh, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

70 A Randomized, Double-Blind, Placebo-C

✍ Barton, Matthew E.; Otiker, Tal; Johnson, Lakshmi Vasist; Robertson, Darren C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 218 KB